ArticleSleep & breathing = Schlaf & Atmung2026
Sleep phenotypes and clinical outcomes in individuals with chronic obstructive pulmonary disease: A cohort study.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn COPD, most studies have examined sleep characteristics in isolation, and limited evidence exists regarding sleep phenotypes and their impact on clinical outcomes.
objectiveTo prospectively investigate the impact of sleep phenotypes on several relevant clinical outcomes in individuals with COPD.
methodsBased on sleep nighttime assessed at baseline by both objective and subjective methods, individuals were classified into different sleep phenotypes: ‘short sleep’ and ‘high propensity to sleep + average sleep’. Furthermore, in a prospective cohort, individuals were assessed at baseline and after 12 months for lung function, body composition, peripheral muscle strength, functional capacity, daily physical activity (PA) and symptoms of dyspnea, anxiety, and depression.
resultsTwenty-nine individuals with COPD were analyzed. In both subjective and objective assessments, the ‘short sleep’ phenotype showed worsening in more outcomes when compared to the other phenotype, with significant worsening in FEV1 (p = 0.038), dyspnea (p = 0.020), light-intensity PA as % of the day (p = 0.028), sedentary time as % of the day (p = 0.028) and peripheral muscle strength (p = 0.003). Repeated-measures ANOVA showed a significant main effect of time for light PA and sedentary time, with large effect sizes. There was no significant interaction between time and subjective sleep phenotypes, although sedentary time showed a borderline result.
conclusionIndividuals with COPD who present the ‘short sleep’ phenotype show significant worsening in lung function, daily PA and peripheral muscle strength over 12 months. Furthermore, the interaction between sleep duration and phenotype may influence physical activity and sedentary behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.